Mutagenicity of volatile anesthetics: halothane

Area of Science:

• Toxicology
• Microbiology
• Pharmacology

Background:

• Halothane is a widely used inhalational anesthetic.
• Concerns about potential mutagenicity of anesthetics necessitate rigorous safety evaluations.
• Understanding the genotoxic potential of halothane is crucial for patient safety.

Purpose of the Study:

• To evaluate the mutagenicity of halothane using an in-vitro microbial assay.
• To assess the mutagenic potential of halothane's major metabolite, trifluoroacetic acid.
• To investigate the mutagenicity of urine from patients exposed to halothane.

Main Methods:

• Utilized Salmonella typhimurium strains TA98 and TA100 for mutagenicity testing.
• Incubated halothane (0.1-30%) with bacteria, with and without metabolic activation (rat/human liver systems).
• Tested trifluoroacetic acid and patient urine samples in the same microbial assay system.

Main Results:

• Halothane did not exhibit mutagenic activity across the tested concentrations.
• Trifluoroacetic acid, a key halothane metabolite, was found to be non-mutagenic.
• Urine samples from patients undergoing halothane anesthesia showed no mutagenic effects.

Conclusions:

• Halothane is not mutagenic in the Salmonella typhimurium assay system.
• The tested metabolite and patient urine samples also lack mutagenic properties.
• These findings suggest a low genotoxic risk associated with halothane anesthesia.